Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

被引:6
|
作者
Jensen, Christoph J. [1 ]
Naber, Christoph K. [1 ]
Urban, Philip [2 ]
Ong, Paul J. [3 ]
Valdes-Chavarri, Mariano [4 ]
Abizaid, Alexandre A. [5 ]
Pocock, Stuart J. [6 ]
Fabbiocchi, Franco [7 ]
Dubois, Christophe [8 ]
Copt, Samuel [9 ]
Stoll, Hans-Peter [9 ]
Morice, Marie-Claude [10 ]
机构
[1] Elisabeth Krankenhaus Essen, Contilia Heart & Vasc Ctr, Essen, Germany
[2] Hosp la Tour, Geneva, Switzerland
[3] Tan Tock Seng Hosp, Singapore, Singapore
[4] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[5] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[6] London Sch Hyg & Trop Med, London, England
[7] Ctr Cardiol Monzino, Milan, Italy
[8] Univ Ziekenhuizen Leuven, Dept Cardiovasc Med, Leuven, Belgium
[9] Biosensors Europe, Morges, Switzerland
[10] CERC, Massy, France
关键词
2017; ESC;
D O I
10.4244/EIJ-D-17-00720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1946 / 1949
页数:4
相关论文
共 48 条
  • [21] Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial
    Richardt, Gert
    Abdelghani, Mohammad
    Allali, Abdelhakim
    Toelg, Ralph
    Abdellaoui, Mohamed
    Krackhardt, Florian
    Wiseth, Rune
    Morice, Marie-Claude
    Cope, Samuel
    Stoll, Hans-Peter
    Urban, Philip
    CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (02) : 162 - 171
  • [22] Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial
    Gert Richardt
    Mohammad Abdelghani
    Abdelhakim Allali
    Ralph Toelg
    Mohamed Abdellaoui
    Florian Krackhardt
    Rune Wiseth
    Marie-Claude Morice
    Samuel Copt
    Hans-Peter Stoll
    Philip Urban
    Clinical Research in Cardiology, 2021, 110 : 162 - 171
  • [23] Ten-Year Clinical Outcomes in Patients With Acute Coronary Syndrome Treated With Biodegradable, Permanent-Polymer or Polymer-Free Drug-Eluting Stents
    Coughlan, J. J.
    Aytekin, Alp
    Lenz, Tobias
    Koch, Tobias
    Wiebe, Jens
    Cassese, Salvatore
    Joner, Michael
    Koppara, Tobias
    Xhepa, Erion
    Kessler, Thorsten
    Ibrahim, Tareq
    Laugwitz, Karl-Ludwig
    Schunkert, Heribert
    Kastrati, Adnan
    Kufner, Sebastian
    JOURNAL OF INVASIVE CARDIOLOGY, 2022, 34 (04): : E266 - +
  • [24] USE OF A POLYMER-FREE BIOLIMUS A9 DRUG- COATED STENT IN DES-TYPE PATIENTS WHO ARE POOR CANDIDATES FOR PROLONGED DAPT
    Butt, Mehmood
    Abdul, Fairoz
    Yazji, Khaled
    Ossei-Gerning, Nick
    Chase, Alex
    Smith, Dave
    Anderson, Richard
    Kinnaird, Tim
    HEART, 2016, 102 : A11 - A11
  • [25] Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy
    Kinnaird, Tim
    Butt, Mehmood
    Abdul, Fairoz
    Yazji, Khaled
    Hailan, Ahmed
    Gallagher, Sean
    Ossei-Gerning, Nicholas
    Chase, Alexander
    Choudhury, Anirban
    Smith, David
    Anderson, Richard
    PLOS ONE, 2016, 11 (06):
  • [26] Real-world analysis of a Biolimus A9 polymer-free drug-coated stent with very short dual antiplatelet therapy in patients at high bleeding risk; [Untersuchung eines polymerfreien medikamentenbeschichteten Biolimus-A9-Stents mit sehr kurzer dualer Plättchenhemmung unter Realbedingungen bei Patienten mit hohem Blutungsrisiko]
    Chatzantonis G.
    Chatzantonis G.
    Findeisen H.
    Paul M.
    Samol A.
    Bisdas T.
    Fischer D.
    Herz, 2021, 46 (3) : 242 - 249
  • [27] Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent
    Mueller-Huelsbeck, Stefan
    Benko, Andrew
    Soga, Yoshimitsu
    Fujihara, Masahiko
    Iida, Osamu
    Babaev, Anvar
    O'Connor, David
    Zeller, Thomas
    Dulas, Daniel D.
    Diaz-Cartelle, Juan
    Gray, William A.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (03) : 368 - 375
  • [28] Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent
    Stefan Müller-Hülsbeck
    Andrew Benko
    Yoshimitsu Soga
    Masahiko Fujihara
    Osamu Iida
    Anvar Babaev
    David O’Connor
    Thomas Zeller
    Daniel D. Dulas
    Juan Diaz-Cartelle
    William A. Gray
    CardioVascular and Interventional Radiology, 2021, 44 : 368 - 375
  • [29] EVALUATION OF THE ACADEMIC RESEARCH CONSORTIUM HIGH BLEEDING RISK DEFINITION IN PATIENTS TREATED WITH DRUG-COATED STENTS AND BARE-METAL STENTS FROM THE LEADERS FREE I & II TRIALS
    Marquis-Gravel, Guillaume
    Urban, Philip M.
    Copt, Samuel
    Slama, Sara Sadozai
    Stoll, Hans-Peter
    Mehran, Roxana
    Capodanno, Davide
    Leon, Martin
    Rao, Sunil
    Pocock, Stuart
    Morice, Marie
    Krucoff, Mitchell
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1502 - 1502
  • [30] Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients Final 2-Year Results From Onyx ONE
    Windecker, Stephan
    Latib, Azeem
    Kedhi, Elvin
    Kirtane, Ajay J.
    Kandzari, David E.
    Mehran, Roxana
    Price, Matthew J.
    Abizaid, Alexandre
    Simon, Daniel, I
    Worthley, Stephen G.
    Zaman, Azfar
    Hudec, Martin
    Poliacikova, Petra
    Ghapar, Abdul Kahar bin Abdul
    Selvaraj, Kamaraj
    Petrov, Ivo
    Mylotte, Darren
    Pinar, Eduardo
    Moreno, Raul
    Fabbiocchi, Franco
    Pasupati, Sanjeevan
    Kim, Hyo-Soo
    Aminian, Adel
    Tie, Charles
    Wlodarczak, Adrian
    Hur, Seung-Ho
    Marx, Steven O.
    Ali, Ziad A.
    Parke, Maria
    Lung, Te-Hsin
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (11) : 1153 - 1163